Literature DB >> 3207529

Concentration-response analysis of percutaneous local anaesthetic formulations.

A D Woolfson1, D F McCafferty, K H McClelland, V Boston.   

Abstract

The percutaneous absorption of amethocaine has been measured for different concentrations of the drug in three different formulations, A, B and C. Statistical analysis indicated that a concentration of 4% produced effective percutaneous local anaesthesia to pin-prick, together with an acceptable onset time of approximately 40 min. Increasing the concentration did not reduce the onset time further, although there was some increase in the duration of anaesthesia. Formulations A and B were hydrophilic, whereas C was an oil-in-water cream. Effective anaesthesia with formulation C required a higher drug concentration (12%), perhaps because of partitioning of the lipophilic anaesthetic into the lipid phase of the vehicle. The rate-limiting step was considered to be diffusion by the lipophilic anaesthetic through the stratum corneum, shown by onset of anaesthesia after removal of the formulation from the test site.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3207529     DOI: 10.1093/bja/61.5.589

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


  3 in total

Review 1.  A critical review of the topical local anesthetic amethocaine (Ametop) for pediatric pain.

Authors:  Lisa O'Brien; Anna Taddio; Dorothy A Lyszkiewicz; Gideon Koren
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

2.  Clinical experiences with a novel percutaneous amethocaine preparation: prevention of pain due to venepuncture in children.

Authors:  A D Woolfson; D F McCafferty; V Boston
Journal:  Br J Clin Pharmacol       Date:  1990-08       Impact factor: 4.335

3.  In vitro cutaneous and percutaneous delivery and in vivo efficacy of tetracaine from liposomal and conventional vehicles.

Authors:  M Foldvari
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.